NEW YORK--(BUSINESS WIRE)--Feb. 7, 2005--ImClone Systems Incorporated (NASDAQ:IMCL) announced today that Daniel S. Lynch, Chief Executive Officer, is scheduled to present at the Merrill Lynch 16th Annual Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 9, 2005, from 2:00 PM to 2:40 PM Eastern Time. A Q&A session with the analyst and audience will follow a brief introduction by Mr. Lynch.
